跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DBL CARBOPLATIN 450mg/45mL Injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
DBL CARBOPLATIN 450mg/45mL Injection vial
Approved
STANDARD
DBL CARBOPLATIN 450mg/45mL Injection vial
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
93b54eae66fb6fbe
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
93b54eae66fb6fbe
Product Name
DBL CARBOPLATIN 450mg/45mL Injection vial
Artg Id
46846
Artg Name
DBL CARBOPLATIN 450mg/45mL injection vial
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1994-01-31
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-CMI-01180-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2011-PI-03554-3
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
93b54eae66fb6fbe
Type
Standard
Back to TGA Approvals